PINIX
Price
$14.37
Change
-$0.33 (-2.24%)
Updated
Dec 18 closing price
VTSNX
Price
$128.84
Change
-$2.68 (-2.04%)
Updated
Dec 18 closing price
Ad is loading...

PINIX vs VTSNX

Header iconPINIX vs VTSNX Comparison
Open Charts PINIX vs VTSNXBanner chart's image
Principal International Equity Inst
Price$14.37
Change-$0.33 (-2.24%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$128.84
Change-$2.68 (-2.04%)
VolumeN/A
CapitalizationN/A
PINIX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PINIX vs. VTSNX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PINIX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 443B vs. PINIX (224M). VTSNX pays higher dividends than PINIX: VTSNX (3.29) vs PINIX (2.77). PINIX was incepted earlier than VTSNX: PINIX (21 years) vs VTSNX (14 years). PINIX is a more actively managed with annual turnover of: 65.80 vs. VTSNX (4.00). PINIX has a lower initial minimum investment than VTSNX: PINIX (0) vs VTSNX (5000000). PINIX annual gain was more profitable for investors over the last year : 13.51 vs. VTSNX (8.83). VTSNX return over 5 years is better than : 14.00 vs. PINIX (2.66).
PINIXVTSNXPINIX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years14 years-
Gain YTD10.3606.076171%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets224M443B0%
Annual Yield % from dividends2.773.2984%
Returns for 1 year13.518.83153%
Returns for 3 years-13.961.10-1,264%
Returns for 5 years2.6614.0019%
Returns for 10 years29.2935.7282%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GSK34.230.65
+1.94%
GSK plc
CTO20.530.03
+0.15%
CTO Realty Growth
BPOP93.88-1.86
-1.94%
Popular
DNOW13.80-0.47
-3.29%
DNOW
AKTS0.04N/A
-9.05%
Akoustis Technologies